People's United Financial’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$17.9M Sell
152,233
-18,675
-11% -$2.1M 0.51% 54
2021
Q4
$22.1M Sell
170,908
-6,941
-4% -$810K 0.53% 53
2021
Q3
$20.1M Sell
177,849
-3,922
-2% -$448K 0.45% 60
2021
Q2
$18.8M Sell
181,771
-543
-0.3% -$51.2K 0.42% 67
2021
Q1
$15.2M Sell
182,314
-14,254
-7% -$1.21M 0.36% 74
2020
Q4
$17.9M Sell
196,568
-9,471
-5% -$786K 0.44% 63
2020
Q3
$16.4M Sell
206,039
-5,276
-2% -$412K 0.46% 68
2020
Q2
$14.6M Buy
211,315
+13,183
+7% +$937K 0.43% 70
2020
Q1
$12.5M Buy
198,132
+7,881
+4% +$568K 0.43% 72
2019
Q4
$14.8M Sell
190,251
-66
-0% -$5.15K 0.4% 66
2019
Q3
$14M Sell
190,317
-6,270
-3% -$440K 0.4% 65
2019
Q2
$12.1M Buy
196,587
+12,726
+7% +$770K 0.33% 76
2019
Q1
$11.7M Buy
183,861
+21,345
+13% +$1.22M 0.36% 68
2018
Q4
$8.3M Buy
162,516
+55,590
+52% +$2.81M 0.29% 81
2018
Q3
$6.19M Buy
106,926
+92,058
+619% +$4.5M 0.19% 114
2018
Q2
$721K Sell
14,868
-531
-3% -$24.8K 0.02% 507
2018
Q1
$716K Sell
15,399
-333
-2% -$14.5K 0.02% 452
2017
Q4
$591K Buy
+15,732
New +$577K 0.02% 489
2017
Q3
Sell
-12,360
Closed -$487K 651
2017
Q2
$487K Hold
12,360
0.02% 491
2017
Q1
$388K Sell
12,360
-9,087
-42% -$284K 0.01% 511
2016
Q4
$670K Buy
21,447
+5,007
+30% +$162K 0.02% 403
2016
Q3
$661K Hold
16,440
0.03% 281
2016
Q2
$547K Hold
16,440
0.03% 319
2016
Q1
$483K Hold
16,440
0.03% 331
2015
Q4
$433K Sell
16,440
-2,400
-13% -$62.3K 0.02% 359
2015
Q3
$446K Hold
18,840
0.03% 351
2015
Q2
$447K Hold
18,840
0.02% 363
2015
Q1
$447K Hold
18,840
0.02% 368
2014
Q4
$400K Hold
18,840
0.02% 373
2014
Q3
$321K Hold
18,840
0.02% 391
2014
Q2
$270K Hold
18,840
0.01% 414
2014
Q1
$233K Hold
18,840
0.01% 396
2013
Q4
$206K Hold
18,840
0.01% 405
2013
Q3
$219K Hold
18,840
0.01% 388
2013
Q2
$211K Buy
+18,840
New +$223K 0.01% 379

Other funds holding EW

People's United Financial's EW Position: Q1 2022 in Review

People's United Financial reduced its Edwards Lifesciences (EW) stake by 11% in Q1 2022, selling an estimated $2.1M and leaving 152,233 shares worth $17.9M. The position accounts for 0.51% of the portfolio, ranked #54.

People's United Financial first reported a position in EW in Q2 2013 and has held it in 35 quarters since. The position peaked at $22.1M in Q4 2021. 1,315 funds tracked by Wall St. Rank hold EW as of Q1 2022.

  • People's United Financial held 152,233 shares of Edwards Lifesciences worth $17.9M as of Q1 2022.
  • People's United Financial sold 18,675 Edwards Lifesciences shares in Q1 2022, an estimated $2.1M.
  • Edwards Lifesciences made up 0.51% of People's United Financial's portfolio in Q1 2022, its #54 holding.
  • People's United Financial first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 35 quarters since.
  • People's United Financial's Edwards Lifesciences position peaked at $22.1M in Q4 2021.
  • 1,315 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2022.

Based on People's United Financial's 13F filing for Q1 2022, filed 10 May 2022.